{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:03:45Z","timestamp":1784527425378,"version":"3.55.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The association between the gut microbiota and lung cancer remains understudied. In this study, we conducted a comprehensive systematic review and meta-analysis to quantitatively synthesize evidence from multiple cohorts to identify robust and consistent alterations in gut microbial diversity and taxonomy associated with lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic literature search was performed across PubMed, Cochrane Library, Embase, and Web of Science databases up to June 5, 2025. The analysis summarized key microbiota characteristics from the selected studies, including alpha diversity, beta diversity, and relative taxonomic abundance. This meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our systematic search identified 12,810 articles, out of which 27 studies comprising 2,263 individuals, involving 1,234 lung cancer patients and 1,029 non-cancer controls, were included for qualitative synthesis. Meta-analysis revealed a significant reduction in microbial alpha diversity of 25 studies in lung cancer patients. Significant decreases were indicated in the ACE index (SMD\u202f=\u202f\u22120.64, 95% CI: \u22121.14 to \u22120.13), Chao1 index (SMD\u202f=\u202f\u22120.31, 95% CI: \u22120.60 to \u22120.02), and Shannon index (SMD\u202f=\u202f\u22120.25, 95% CI: \u22120.57 to 0.08). Chinese cohorts showed significantly lower Chao1and Shannon by subgroup analysis. Twenty-seven studies assessed beta diversity, in which 20 studies (74.0%) reported a significant difference in overall microbial community structure between lung cancer patients and non-cancer controls. Quantitative meta-analysis by forest plot revealed, compared to non-cancer controls, lung cancer patients exhibited decreased relative abundances of phylum Firmicutes (SMD\u202f=\u202f\u22120.47, 95% CI: \u22120.91 to \u22120.02), and increased abundances of phylum Bacteroidetes (SMD\u202f=\u202f0.53, 95% CI: 0.24 to 0.82). Furthermore, we observed a marked depletion of beneficial short-chain fatty acid producers of genus\n                      <jats:italic>Lachnospira<\/jats:italic>\n                      (SMD\u202f=\u202f\u22121.01, 95% CI: \u22121.29 to \u22120.73).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This meta-analysis demonstrates that lung cancer is consistently associated with gut microbiota dysbiosis characterized by reduced microbial diversity and reproducible taxonomic alterations. Clinically, these findings suggest that gut microbiota may serve as non-invasive biomarkers for lung cancer detection and patient stratification, and may also help predict immunotherapy response and inform future microbiota-targeted therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024537463<\/jats:ext-link>\n                      , CRD42024537463.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1873706","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:35:33Z","timestamp":1784525733000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The composition alteration of gut microbiota in lung cancer: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaona","family":"Xu","sequence":"first","affiliation":[{"name":"Central Laboratory, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yu","sequence":"additional","affiliation":[{"name":"Central Laboratory, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Wu","sequence":"additional","affiliation":[{"name":"Qingdao Traditional Chinese Medicine Hospital, Qingdao Hiser Hospital Affiliated of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory, Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[{"name":"Qingdao Central Hospital, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaozu","family":"Han","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Qingdao Key Laboratory of Common Diseases, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Human Resources Department, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjuan","family":"Yu","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Qingdao Key Laboratory of Common Diseases, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jtho.2019.04.001","article-title":"Lung cancer worldwide","volume":"14","author":"Adjei","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3390\/ijms25042323","article-title":"Detailed characterization of the lung-gut microbiome Axis reveals the link between PD-L1 and the microbiome in non-small-cell lung Cancer patients","volume":"25","author":"Ankudavicius","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41598-024-77864-y","article-title":"Key features and guidelines for the application of microbial alpha diversity metrics","volume":"15","author":"Cassol","year":"2025","journal-title":"Sci. Rep."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1186\/s12885-021-08530-z","article-title":"Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer","volume":"21","author":"Chau","year":"2021","journal-title":"BMC Cancer"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"885093","DOI":"10.3389\/fcimb.2022.885093","article-title":"Combined microbiome and metabolome analysis reveals a novel interplay between intestinal Flora and Serum metabolites in lung Cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/cac2.12359","article-title":"Non-small cell lung cancer in China","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1390722","DOI":"10.3389\/fmicb.2024.1390722","article-title":"Immune cells mediated the causal relationship between the gut microbiota and lung cancer: a Mendelian randomization study","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Microbiol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.7150\/jca.92699","article-title":"Causal relationships between gut microbiota, immune cell, and non-small cell lung cancer: a two-step, two-sample Mendelian randomization study","volume":"15","author":"Chen","year":"2024","journal-title":"J. Cancer"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12916-023-02863-1","article-title":"Cross-talks between gut microbiota and tobacco smoking: a two-sample Mendelian randomization study","volume":"21","author":"Fan","year":"2023","journal-title":"BMC Med."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.3390\/ijms25073768","article-title":"Dynamic changes of the gut microbiota and its functional metagenomic potential during the development of non-small cell lung Cancer","volume":"25","author":"Feng","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/microorganisms11030546","article-title":"Association studies on gut and lung microbiomes in patients with lung adenocarcinoma","volume":"11","author":"Guo","year":"2023","journal-title":"Microorganisms"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1038\/s41598-023-29136-4","article-title":"Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit","volume":"13","author":"Haberman","year":"2023","journal-title":"Sci. Rep."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut\u2013liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.chest.2021.12.655","article-title":"Distribution, risk factors, and temporal trends for lung cancer incidence and mortality: a global analysis","volume":"161","author":"Huang","year":"2022","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1211855","DOI":"10.3389\/fcimb.2023.1211855","article-title":"Gut microbiota and its metabolites in non-small cell lung cancer and brain metastasis: from alteration to potential microbial markers and drug targets","volume":"13","author":"Jiang","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.4014\/jmb.1709.09027","article-title":"Deciphering diversity indices for a better understanding of microbial communities","volume":"27","author":"Kim","year":"2017","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"8026","DOI":"10.3390\/ijms25158026","article-title":"Microbial and metabolic gut profiling across seven malignancies identifies fecal Faecalibacillus intestinalis and formic acid as commonly altered in Cancer patients","volume":"25","author":"Kulecka","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"217096","DOI":"10.1016\/j.canlet.2024.217096","article-title":"Gut microbial metabolites in lung cancer development and immunotherapy: novel insights into gut-lung axis","volume":"598","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1200299","DOI":"10.3389\/fcimb.2023.1200299","article-title":"Revealing a causal relationship between gut microbiota and lung cancer: a Mendelian randomization study","volume":"13","author":"Li","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.7150\/ijbs.35980","article-title":"Dysbiosis of the gut microbiome is associated with tumor biomarkers in lung Cancer","volume":"15","author":"Liu","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41698-020-00138-z","article-title":"Microbiome dysbiosis in lung cancer: from composition to therapy","volume":"4","author":"Liu","year":"2020","journal-title":"NPJ Precision Oncology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"104322","DOI":"10.1016\/j.critrevonc.2024.104322","article-title":"Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies","volume":"196","author":"Liu","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e0080221","DOI":"10.1128\/Spectrum.00802-21","article-title":"Alterations of the human lung and gut microbiomes in non-small cell lung carcinomas and distant metastasis","volume":"9","author":"Lu","year":"2021","journal-title":"Microbiol. Spectrum"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1170326","DOI":"10.3389\/fcimb.2023.1170326","article-title":"Structure of gut microbiota and characteristics of fecal metabolites in patients with lung cancer","volume":"13","author":"Lu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13045-022-01273-9","article-title":"Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies","volume":"15","author":"Lu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-023-02825-6","article-title":"Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites","volume":"24","author":"Luan","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/gutjnl-2025-334922","article-title":"Smoking affects gut immune system of patients with inflammatory bowel diseases by modulating metabolomic profiles and mucosal microbiota","volume":"75","author":"Miyauchi","year":"2025","journal-title":"Gut"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-025-02348-0","article-title":"Biofilm formation by the host microbiota: a protective shield against immunity and its implication in cancer","volume":"24","author":"Montanari","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41571-023-00794-7","article-title":"Immune-checkpoint inhibition for resectable non-small-cell lung cancer\u2014opportunities and challenges","volume":"20","author":"Mountzios","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ccell.2024.01.010","article-title":"Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade","volume":"42","author":"Nabet","year":"2024","journal-title":"Cancer Cell"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1091825","DOI":"10.3389\/fcimb.2023.1091825","article-title":"Combined analysis of gut microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer","volume":"13","author":"Ni","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e947","DOI":"10.1002\/ctm2.947","article-title":"Integrated microbiome, metabolome, and proteome analysis identifies a novel interplay among commensal bacteria, metabolites and candidate targets in non-small cell lung cancer","volume":"12","author":"Qian","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"918823","DOI":"10.3389\/fmicb.2022.918823","article-title":"Dysbiosis of the gut microbiome is associated with histopathology of lung cancer","volume":"13","author":"Qin","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1038\/s41467-020-18983-8","article-title":"The human microbiome in the 21st century","volume":"11","author":"Rackaityte","year":"2020","journal-title":"Nat. Commun."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"eabc4552","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11274-021-03086-3","article-title":"Association of gut microbiomes with lung and esophageal cancer: a pilot study","volume":"37","author":"Shen","year":"2021","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"10401","DOI":"10.1039\/d3fo04051h","article-title":"Akkermansia muciniphila attenuated lipopolysaccharide-induced acute lung injury by modulating the gut microbiota and SCFAs in mice","volume":"14","author":"Shen","year":"2023","journal-title":"Food Funct."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.21873\/anticanres.17331","article-title":"A prospective observational study analyzing the diversity and specific composition of the oral and gut microbiota in lung cancer patients","volume":"44","author":"Shoji","year":"2024","journal-title":"Anticancer Res."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1126\/science.abm7759","article-title":"Codiversification of gut microbiota with humans","volume":"377","author":"Suzuki","year":"2022","journal-title":"Science"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/biomedicines12030703","article-title":"Gut microbiota signatures with potential clinical usefulness in colorectal and non-small cell lung cancers","volume":"12","author":"Tesolato","year":"2024","journal-title":"Biomedicine"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/cancers16010047","article-title":"Association of Clostridium butyricum therapy using the live bacterial product CBM588 with the survival of patients with lung cancer receiving chemoimmunotherapy combinations","volume":"16","author":"Tomita","year":"2023","journal-title":"Cancers (Basel)"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"14648","DOI":"10.1021\/acsomega.3c05846","article-title":"Short-chain fatty acid (SCFA) as a connecting link between microbiota and gut-lung axis\u2500 a potential therapeutic intervention to improve lung health","volume":"9","author":"Verma","year":"2024","journal-title":"ACS Omega"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"790467","DOI":"10.3389\/fonc.2022.790467","article-title":"Gut microbiome was highly related to the regulation of metabolism in lung adenocarcinoma patients","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e30380","DOI":"10.1016\/j.heliyon.2024.e30380","article-title":"Alteration of the gut microbiota in patients with lung cancer accompanied by chronic obstructive pulmonary diseases","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/J.ENG.2017.01.008","article-title":"The human microbiota in health and disease","volume":"3","author":"Wang","year":"2017","journal-title":"Engineering"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"15991","DOI":"10.3390\/ijerph192315991","article-title":"Impact of gut Dysbiosis on the risk of non-small-cell lung Cancer","volume":"19","author":"Wei","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref55","first-page":"135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume-title":"BMC Med. Res. Methodol.","author":"Xiang Wan","year":"2014"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.1038\/s41467-021-27112-y","article-title":"Dysbiosis of human gut microbiome in young-onset colorectal cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"102234","DOI":"10.1016\/j.xcrm.2025.102234","article-title":"Perioperative administration of CBM588 in colorectal cancer radical surgery: a single-center, randomized controlled trial","volume":"6","author":"Yang","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","article-title":"Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"117522","DOI":"10.1016\/j.ecoenv.2024.117522","article-title":"The causal relationship of cigarette smoking to metabolic disease risk and the possible mediating role of gut microbiota","volume":"290","author":"Zhang","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref60","first-page":"3171","article-title":"Alterations of fecal bacterial communities in patients with lung cancer","volume":"10","author":"Zhang","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.21037\/apm-20-2183","article-title":"The gut microbiome can be used to predict the gastrointestinal response and efficacy of lung cancer patients undergoing chemotherapy","volume":"9","author":"Zhang","year":"2020","journal-title":"Ann Palliat Med"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"725284","DOI":"10.3389\/fcimb.2021.725284","article-title":"Specific gut microbiome and serum metabolome changes in lung Cancer patients","volume":"11","author":"Zhao","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1002\/cam4.5312","article-title":"Bifidobacterium breve predicts the efficacy of anti-PD-1 immunotherapy combined with chemotherapy in Chinese NSCLC patients","volume":"12","author":"Zhao","year":"2023","journal-title":"Cancer Med."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1080\/19490976.2020.1737487","article-title":"Specific gut microbiome signature predicts the early-stage lung cancer","volume":"11","author":"Zheng","year":"2020","journal-title":"Gut Microbes"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fcimb.2019.00112","article-title":"Dysbiosis of the gut microbiome in lung Cancer","volume":"9","author":"Zhuang","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1873706\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:35:34Z","timestamp":1784525734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1873706\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":65,"alternative-id":["10.3389\/fmicb.2026.1873706"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1873706","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"article-number":"1873706"}}